The treatment of functional dyspepsia: present and future

References

• Stanghellini V, Chan FKL, Hasler WL, et al., Gastroduodenal Disorders. Gastroenterology. 2016. 150(6): 1380–1392.
   PubMed Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99–114.
   PubMed Web of Science ®Google Scholar
• Aro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology. 2009;137(1):94–100.
   PubMed Web of Science ®Google Scholar
• Zagari RM, Law GR, Fuccio L, et al. Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study. Gastroenterology. 2010;138(4):1302–1311.
   PubMed Web of Science ®Google Scholar
• Aziz I, Palsson OS, Törnblom H, et al. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3(4):252–262.
   PubMed Web of Science ®Google Scholar
• Ford AC, Mahadeva S, Carbone MF, et al. Functional dyspepsia. Lancet. 2020;396(10263):1689–1702.
   PubMed Web of Science ®Google Scholar
• Wauters L, Talley NJ, Walker MM, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut. 2020;69(3):591–600.
   PubMed Web of Science ®Google Scholar
• Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III Criteria. Am J Gastroenterol. 2017;112(1):132–140.
   PubMed Web of Science ®Google Scholar
• Pesce M, Cargiolli M, Cassarano S, et al. Diet and functional dyspepsia: clinical correlates and therapeutic perspectives. World J Gastroenterol. 2020;26(8):456–465.
   PubMedGoogle Scholar
• Lacy BE, Weiser KT, Kennedy AT, et al. Functional dyspepsia: the economic impact to patients. Aliment Pharm Ther. 2013;38(2):170–177.
   PubMed Web of Science ®Google Scholar
• Aro P, Talley NJ, Agreus L, et al. Functional dyspepsia impairs quality of life in the adult population. Aliment Pharmacol Ther. 2011;33(11):1215–1224.
   PubMed Web of Science ®Google Scholar
• Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol. 2002;97(9):2290–2299.
   PubMed Web of Science ®Google Scholar
• Mahadeva S, Yadav H, Everett SM, et al. Factors influencing dyspepsia-related consultation: differences between a rural and an urban population. Neurogastroenterol Motil. 2011;23(9):846–853.
   PubMed Web of Science ®Google Scholar
• Ford AC, Forman D, Bailey AG, et al. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study. Am J Gastroenterol. 2007;102(5):957–965.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Yu J, Crowell MD. Medication risk-taking behavior in functional dyspepsia patients. Clin Transl Gastroenterol. 2015;6(1):e69.
   PubMedGoogle Scholar
• Goyal O, Nohria S, Batta S, et al., Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet versus traditional dietary advice for functional dyspepsia: a randomized controlled trial. J Gastroenterol Hepatol. 2021. 37(9): 301–309.
   PubMedGoogle Scholar
• Hooi JKY, Lai WY, Ng WK, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420–429.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Forman D, Braunholtz D, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 2000;95(6):1448–1455.
   PubMed Web of Science ®Google Scholar
• Moayyedi PM, Lacy BE, Andrews CN, et al., ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017. 112(7): 988–1013.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr;19(2):CD002096.
   Google Scholar
• Oshima T, Okugawa T, Tomita T, et al. Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects. Aliment Pharmacol Ther. 2012;35(1):175–182.
   PubMed Web of Science ®Google Scholar
• Samsom M, Verhagen MA, vanBerge Henegouwen GP, et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology. 1999;116(3):515–520.
   PubMed Web of Science ®Google Scholar
• Quigley E, Lacy BE. The overlap of functional dyspepsia with GERD. Clinical considerations and treatment implications. Nat Rev Gastroenterol Hepatol. 2013;10:175–186.
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Shelly S, Deeks JJ, et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2011 Feb;16(2):CD001960.
   Google Scholar
• Pinto-Sanchez MI, Yuan Y, Hassan A, et al. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017 Nov 21;11:CD011194.
   PubMedGoogle Scholar
• McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med. 1998;339(26):1869–1874.
   PubMed Web of Science ®Google Scholar
• Cangemi DJ, Lacy BD. Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum? Curr Opin Gastroenterol. 2020;36(6):509–517.
   PubMed Web of Science ®Google Scholar
• Mazzoleni LE, Sander GB, Francesconi CF, et al. Helicobacter pylori eradication in functional dyspepsia: Heroes trial. Arch Intern Med. 2011;171(21):1929–1936.
   PubMedGoogle Scholar
• Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;134(3):361–369.
   PubMedGoogle Scholar
• Tan VP, Liu KS, Lam FY, et al. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia. Aliment Pharmacol Ther. 2017;45(6):767–776.
   PubMed Web of Science ®Google Scholar
• Gurusamy SR, Shah A, Talley NJ, et al. Small intestinal bacterial overgrowth in functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol. 2021;116(5):935–942.
   PubMed Web of Science ®Google Scholar
• Ohtsu T, Takagi A, Uemura N, et al. The ameliorating effect of Lactobacillus gasseri OLL2716 on functional dyspepsia in Helicobacter Pylori-uninfected individuals: a randomized controlled study. Digestion. 2017;96(2):92–102.
   PubMed Web of Science ®Google Scholar
• Wauters L, Slaets H, De Paepe K, et al. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2021;6(10):784–792.
   PubMed Web of Science ®Google Scholar
• Liu B, Fan L, Balakrishna S, et al. TRPM8 Is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 2013;154(10):2169–2177.
   PubMed Web of Science ®Google Scholar
• Juergens UR, Stober M, Vetter H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur J Med Res. 1998;3(12):539–545.
   PubMedGoogle Scholar
• Micklefield G, Jung O, Irmgard G, et al. Effects of intraduodenal application of peppermint oil (WS 1340) and caraway oil (WS 1520) on gastroduodenal motility in healthy volunteers. Phytother Res. 2003;17(2):135–140.
   PubMed Web of Science ®Google Scholar
• Rich G, Shah A, Koloski N, et al. A randomized placebo-controlled trial on the effects of menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia. Neurogastroenterol Motil. 2017;29(11):e13132.
   Web of Science ®Google Scholar
• Rozza AL, Meira De Faria F, Souza Brito AR, et al. The gastroprotective effect of menthol: involvement of anti-apoptotic, antioxidant and anti-inflammatory activities. PLoS ONE. 2014;9(1):1–6.
   Web of Science ®Google Scholar
• Chey WD, Lacy BE, Cash BD, et al. A novel, duodenal-release formulation of a combination of caraway oil and L-menthol for the treatment of functional dyspepsia: a randomized controlled trial. Clin Transl Gastroenterol. 2019;10(4):e00021.
   PubMedGoogle Scholar
• Lacy BE, Chey WD, Epstein MS, et al. A novel duodenal-release formulation of caraway oil and L-menthol is safe, effective and well tolerated therapy for functional dyspepsia. BMC Gastroenterol. 2022;22(1):105.
   PubMed Web of Science ®Google Scholar
• Karamanolis G, Caenepeel P, Arts J, et al. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology. 2006;130(2):296–303.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Crowell MD, Cangemi DJ, et al. Diagnostic evaluation of gastric motor and sensory disorders. Am J Gastroenterol. 2021;116(12):2345–2356.
   PubMed Web of Science ®Google Scholar
• Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012;10(11):1239–1245.
   PubMed Web of Science ®Google Scholar
• Miwa H, Nagahara A, Tominaga K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009;104(11):2779–2787.
   PubMed Web of Science ®Google Scholar
• Tack J, Ly HG, Carbone F, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14(3):385–392.
   PubMed Web of Science ®Google Scholar
• Matsueda K, Hongo M, Tack J, et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012;61(6):821–828.
   PubMed Web of Science ®Google Scholar
• Ford AC, Luthra P, Tack J, et al. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66(3):411–420.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Locke GR, Saito YA, et al., Effect of amitriptyline and escitalopram on functional dyspepsia: a multi-center, randomized, controlled study. Gastroenterology. 2015. 149(2): 340–349.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Saito YA, Camilleri M, et al. Effects of antidepressants on gastric function in patients with functional dyspepsia. Am J Gastroenterol. 2018;113(2):216–224.
   PubMed Web of Science ®Google Scholar
• Cheong PK, Ford AC, Cheung CKY, et al. Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatolog. 2018;3(12):837–844.
   PubMed Web of Science ®Google Scholar
• Kaosombatwattana U, Pongprasobchai S, Limsrivilai J, et al. Efficacy and safety of nortriptyline in functional dyspepsia in Asians: a randomized double-blind placebo-controlled trial. J Gastroenterol Hepatol. 2018;33(2):411–417.
   PubMed Web of Science ®Google Scholar
• Asano H, Tomita T, Nakamura K, et al. Prevalence of gastric motility disorders in patients with functional dyspepsia. J Neurogastroenterol Motil. 2017;23(3):392–399.
   PubMed Web of Science ®Google Scholar
• Pittayanon R, Yuan Y, Bollegala NP, et al., Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials. Am J Gastroenterol. 2019. 114(2): 233–243.
   PubMed Web of Science ®Google Scholar
• Orive M, Barrio I, Orive VM, et al. A randomized controlled trial of a 10-week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosomat Res. 2015;78(6):563–568.
   PubMed Web of Science ®Google Scholar
• Haug TT, Wilhelmsen I, Svebak S, et al. Psychotherapy in functional dyspepsia. J Psychosom Res. 1994;38(7):735–744.
   PubMed Web of Science ®Google Scholar
• Calvert EL, Houghton LA, Cooper P, et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002;123(6):1778–1785.
   PubMed Web of Science ®Google Scholar
• Kinsinger SW, Joyce C, Venu M, et al. Pilot study of a self-administered hypnosis intervention for functional dyspepsia. Dig Dis Sci. 2022;67(7):3017–3025.
   PubMed Web of Science ®Google Scholar
• Chiarioni G, Vantini I, De Iorio F, et al. Prokinetic effect of gut-oriented hypnosis on gastric emptying. Aliment Pharmacol Ther. 2006;23(8):1241–1249.
   PubMed Web of Science ®Google Scholar
• Lahner E, Bellentani S, Bastiani RD, et al. A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders. United European Gastroenterol J. 2013;1(5):385–393.
   PubMed Web of Science ®Google Scholar
• Chiarioni G, Pesce M, Fantin A, et al. Complementary and alternative treatment in functional dyspepsia. United European Gastroenterol J. 2018;6(1):5–12.
   PubMed Web of Science ®Google Scholar
• Holtmann G, Adam B, Haag S, et al. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003;18(11–12):1099–1105.
   PubMed Web of Science ®Google Scholar
• Hu ML, Rayner CK, Wu KL, et al. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J Gastroenterol. 2011;17(1):105–110.
   PubMed Web of Science ®Google Scholar
• Panda SK, Nirvanashetty S, Parachur VA, et al. A randomized, double-blind, placebo controlled, parallel-group, comparative clinical study to evaluate the efficacy and safety of OLNP-06 versus placebo in subjects with functional dyspepsia. J Diet Suppl. 2022;19(2):226–237.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Karbasi A, Valizadegan G, et al. Effect of curcumin on severity of functional dyspepsia: a triple blinded clinical trial. Adv Exp Med Biol. 2021;1308:119–126.
   PubMed Web of Science ®Google Scholar
• Yongwatana K, Harinwan K, Chirapongsathorn S, et al. Curcuma longa linn versus omeprazole in treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2022;37(2):335–341.
   PubMed Web of Science ®Google Scholar
• Rösch W, Vinson B, Sassin I. A randomised clinical trial comparing the efficacy of an herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z Gastroenterol. 2002;40(6):401–408.
   PubMed Web of Science ®Google Scholar
• Braden B, Caspary W, Börner N, et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis. Neurogastroenterol Motil. 2009;21(6):632–8, e25.
   PubMed Web of Science ®Google Scholar
• Madisch A, Melderis H, Mayr G, et al. A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study. Z Gastroenterol. 2001;39(7):511–517.
   PubMed Web of Science ®Google Scholar
• Madisch A, Holtmann G, Mayr G, et al. Treatment of functional dyspepsia with an herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion. 2004;69(1):45–52.
   PubMed Web of Science ®Google Scholar
• Gerhardt F, Benesic A, Tillmann HL, et al. Iberogast-induced acute liver failure-reexposure and in vitro assay support causality. Am J Gastroenterol. 2019;114(8):1358–1359.
   PubMed Web of Science ®Google Scholar
• Tominaga K, Sakata Y, Kusunoki H, et al. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: a randomized clinical trial (the DREAM study). Neurogastroenterol Motil. 2018;30(7):e13319.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Matsuzaki J, Fukushima Y, et al. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia–a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil. 2014;26(7):950–961.
   PubMed Web of Science ®Google Scholar
• Arai M, Matsumura T, Tsuchiya N, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012;59(113):62–66.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Li Y, Shu J, et al. The efficacy of oral zhizhu kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome. J Gastroenterol Hepatol. 2019;34(3):526–531.
   PubMed Web of Science ®Google Scholar
• Wen YD, Lu F, Zhao YP, et al. Epigastric pain syndrome: what can traditional Chinese medicine do? A randomized controlled trial of biling weitong granules. World J Gastroenterol. 2020;26(28):4170–4181.
   PubMed Web of Science ®Google Scholar
• Su Q, Chen SL, Wang HH, et al. A randomized, double-blind, multicenter, placebo-controlled trial of qi-zhi-wei-tong granules on postprandial distress syndrome-predominant functional dyspepsia. Chin Med J (Engl). 2018;131(13):1549–1556.
   PubMed Web of Science ®Google Scholar
• Du HG, Ming L, Chen SJ, et al. Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression. World J Gastroenterol. 2014;20(44):16739–16744.
   PubMed Web of Science ®Google Scholar
• Chen G, Feng P, Wang S, et al. An herbal formulation of jiawei xiaoyao for the treatment of functional dyspepsia: a multicenter, randomized, placebo-controlled, clinical trial. Clin Transl Gastroenterol. 2020;11(10):e00241.
   PubMed Web of Science ®Google Scholar
• Mao X, Guo S, Ni W, et al. Electroacupuncture for the treatment of functional dyspepsia: a systemic review and meta-analysis. Medicine (Baltimore). 2020;99(45):e23014.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hou YQ, Yang JW, et al. Acupuncture of different treatment frequency in postprandial distress syndrome: a pilot randomized clinical trial. Neurogastroenterol Motil. 2020 Jun;32(6):e13812.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2009;5:1175–1183.
   Web of Science ®Google Scholar
• Walker MM, Aggarwal KR, Shim LSE, et al. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. Gastroenterol Hepatol. 2014;29:474–479.
   Google Scholar
• Wauters L, Nightingale S, Talley NJ, et al. Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort. Aliment Pharmacol Therapeut. 2017;45:1258–1264.
   Web of Science ®Google Scholar
• Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Therapeut. 2009;29:765–773.
   PubMed Web of Science ®Google Scholar
• Nojkov B, Zhou S, Dolan RD, et al. Evidence of duodenal epithelial barrier impairment and increased pyroptosis in patients with functional dyspepsia on confocal laser endomicroscopy and “ex vivo” mucosal analysis. Am J Gastroenterol. 2020;115:1891–1901.
   PubMed Web of Science ®Google Scholar
• Coeffier M, Dechelotte P, Ducrotte P. Intestinal permeability in patients with diarrhea-predominant irritable bowel syndrome: is there a place for glutamine supplementation? Gastroenterology. 2015;148:1079–1080.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Verne ML, Fields JZ, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019;68:996–1002.
   PubMed Web of Science ®Google Scholar
• Pourmand A, Davis S, Whiteside T, et al. Virtual reality as a clinical tool for pain management. Curr Pain Headache Rep. 2018;22:53.
   PubMed Web of Science ®Google Scholar
• Malloy K, Milling L. The effectiveness of virtual reality distraction for pain reduction: a systemic review. Clin Pyschol Rev. 2010;8:1011–1018.
   Google Scholar
• Sato K, Fukumori S, Matsusaki T, et al. Nonimmersive virtual reality mirror visual feedback therapy and its application for the treatment of complex regional pain syndrome: an open-label pilot study. Pain Med. 2010;4:622–629.
   Google Scholar
• Tashjian VC, Mosadeghi S, Howard AR, et al. Virtual reality for management of pain in hospitalized patients: results of a controlled trial. JMIR Ment Health. 2017;4:e9.
   PubMed Web of Science ®Google Scholar
• Wauters L, Dickman R, Drug V, et al. United European Gastroenterology (UEG) and European society for neurogastroenterology and motility consensus on functional dyspepsia. Neurogastroenterol Motil. 2021;33e:14238.
   Google Scholar
• Huang X, Oshima T, Tomita T, et al. Meta-analysis: placebo response and its determinants in functional dyspepsia. Am J Gastroenterol. 2021;116:2184–2196.
   PubMed Web of Science ®Google Scholar